Natalizumab and HSV meningitis

Journal of NeuroVirology

Volumn 17, Issue 3, 2011, Pages 288-290

  Shenoy, Erica Seiguer ^a,b   Mylonakis, Eleftherios ^a,b   Hurtado, Rocio M ^a,b   Venna, Nagagopal ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPICILLIN; BETA1A INTERFERON; CEFTRIAXONE; GLATIRAMER; GLUCOSE; NATALIZUMAB; OLIGOCLONAL BAND; OSELTAMIVIR; PROTEIN; VALACICLOVIR; VANCOMYCIN;

ADULT; ARTICLE; ASTHMA; BACTERIAL MENINGITIS; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CHILL; DEPRESSION; DRUG MECHANISM; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATIGUE; FEMALE; FEVER; FOLLOW UP; GAIT DISORDER; GLUCOSE BLOOD LEVEL; GRAM STAINING; HEADACHE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HOSPITAL ADMISSION; HUMAN; INFLUENZA A (H1N1); INJECTION SITE REACTION; LEUKOCYTE COUNT; LISTERIOSIS; LUMBAR PUNCTURE; LYMPHOCYTE COUNT; LYMPHOCYTOSIS; MONOCYTE; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; MUSCLE STIFFNESS; NECK MUSCLE; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; NEUTROPHIL COUNT; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOPHOBIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPEECH DISORDER; TOUCH; TREATMENT RESPONSE; VIBRATION SENSE; VIRUS MENINGITIS; VIRUS REACTIVATION;

ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; CROHN DISEASE; FEMALE; HERPES SIMPLEX; HERPESVIRUS 2, HUMAN; HERPESVIRUS 3, HUMAN; HUMANS; INTEGRIN ALPHA4; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MENINGITIS, VIRAL; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING;

HERPES; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 3; SIMPLEXVIRUS;

EID: 79959985339     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-011-0027-4     Document Type: Article

References (10)

1. Von Andrian UH, Engelhardt B (2003) α4 Integrins as therapeutic agents in autoimmune disease. N Engl J Med 348:68-72 (Pubitemid 36026351)
2. Miller DH, Khan OA, Sheremata WA et al (2003) A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 348:15-23 (Pubitemid 36026342)
3. Ghosh S, Goldin E, Gordon FH et al (2003) Natalizumab for active Chron's disease. N Engl J Med 348:24-32
4. Van Assche G, Van Ranst M, Sciot R et al (2005) Progressive multifocal leukencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med 353:362-368 (Pubitemid 41132340)
5. Langer-Gould A, Atlas SW, Green AJ et al (2005) Progressive multifocal leukencephalopathy in a patient treated with natalizumab. N Engl J Med 353:375-381 (Pubitemid 41132342)
6. Scheiss N, Zong J, Hayward G, Calabresi P et al. (2009) Reactivation of herpes virus in multiple sclerosis patients on natalizumab therapy [P03.163]. Poster presentation, April 29, 2009 at the American Academy of Neurology
7. Thursky KA, Worth LJ, Seymour JF (2005a) Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab. Br J Haematol 132:3-12 (Pubitemid 43381565)
8. CAMMS223 Trial Investigators, Coles AJ, Compston DA, Selmaj KW, Lake SL, Moran S, Margolin DH, Norris K, Tandon PK (2008) Alemtuzumab vs. interferon beta-1a in early multiple sclerosis. N Engl J Med 359(17):1786-1801
9. Thursky KA, Worth LJ, Seymour JF et al (2005b) Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab. Br J Haematol 132:3-12 (Pubitemid 43381565)
10. Berger JR, Houff S (2008) Neurological complications of herpes simplex virus type 2 infection. Arch Neurol 65:596-600 (Pubitemid 351679652)